Rezafungin

DRUG3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Hartford Hospital, Fernanda P Silveira, MD, MS

Conditions

Fungal InfectionLiver Transplant InfectionSepsis

Phase 1

Safety and Pharmacokinetics of Rezafungin

TerminatedNCT04117607

National Institute of Allergy and Infectious Diseases (NIAID)Fungal Infection

Start: 2019-12-04End: 2020-05-11Updated: 2021-07-16

Rezafungin Pharmacokinetics in Patients on ECMO

WithdrawnNCT06329518

Hartford HospitalSepsis

Start: 2024-07-01End: 2024-12-11Updated: 2024-12-17

Phase 3

Rezafungin Prophylaxis in Liver Transplant

Enrolling by invitationNCT06774144

Fernanda P Silveira, MD, MSFungal Infection, Liver Transplant Infection

Start: 2025-10-15End: 2028-12-31Target: 385Updated: 2025-10-17